ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 245 filers reported holding ISIS PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 1.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $881,000 | -18.0% | 22,204 | +18.8% | 0.01% | -20.0% |
| Q2 2015 | $1,075,000 | +41.4% | 18,686 | +53.1% | 0.01% | +42.9% |
| Q1 2015 | $760,000 | -37.7% | 12,204 | -38.2% | 0.01% | -46.2% |
| Q4 2014 | $1,220,000 | +238.0% | 19,754 | +98.3% | 0.01% | +225.0% |
| Q3 2014 | $361,000 | -52.6% | 9,962 | -61.6% | 0.00% | -60.0% |
| Q2 2014 | $761,000 | +197.3% | 25,958 | +320.8% | 0.01% | +150.0% |
| Q1 2014 | $256,000 | +14.3% | 6,168 | +9.8% | 0.00% | 0.0% |
| Q4 2013 | $224,000 | +176.5% | 5,620 | +161.0% | 0.00% | +100.0% |
| Q3 2013 | $81,000 | +350.0% | 2,153 | +229.7% | 0.00% | – |
| Q2 2013 | $18,000 | – | 653 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 7,202,585 | $270,385,000 | 14.71% |
| DOWLING & YAHNKE LLC | 675,798 | $25,369,000 | 3.98% |
| GARRISON BRADFORD & ASSOCIATES INC | 100,700 | $3,780,000 | 3.87% |
| WILLIAM HARRIS INVESTORS INC | 312,834 | $11,743,000 | 3.67% |
| Meditor Group Ltd | 490,000 | $18,395,000 | 2.59% |
| AVALON CAPITAL MANAGEMENT | 50,943 | $1,912,000 | 1.89% |
| Orinda Asset Management LLC | 14,665 | $551,000 | 1.73% |
| PINNACLE ASSOCIATES LTD | 2,064,760 | $77,511,000 | 1.60% |
| PERKINS CAPITAL MANAGEMENT INC | 52,850 | $1,984,000 | 1.43% |
| NCM Capital Advisers, Inc. | 24,950 | $937,000 | 1.04% |